Home Healthcare Healthcare Services Preclinical CRO Market

Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Bioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others), By Model (Patient-Derived Organoid (PDO) Model, Patient-Derived Xenograft Model), By Applications (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorders, Others), By End-User (Pharmaceutical and Biotechnological Companies, Government and Academic Institutes, Medical Device Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Jay Mehta | Format: | Report Code: SR4754DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Preclinical CRO Market Size Analysis
    1. Introduction
    2. Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Bioanalysis and DMPK studies
        1. In vitro ADME
        2. In-vivo PK
      2. Toxicology Testing
        1. GLP
        2. Non-GLP
      3. Compound Management
        1. Process R&D
        2. Custom Synthesis
        3. Others
      4. Chemistry
        1. Medicinal Chemistry
        2. Computation Chemistry
      5. Safety Pharmacology
      6. Others
    3. Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
      1. Patient-Derived Organoid (PDO) Model
      2. Patient-Derived Xenograft Model
    4. Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Neurology
      3. Cardiology
      4. Infectious Diseases
      5. Metabolic Disorders
      6. Others
    5. Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnological Companies
      2. Government and Academic Institutes
      3. Medical Device Companies
      4. Others
  7. North America Preclinical CRO Market Size Analysis
    1. Introduction
    2. Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Bioanalysis and DMPK studies
        1. In vitro ADME
        2. In-vivo PK
      2. Toxicology Testing
        1. GLP
        2. Non-GLP
      3. Compound Management
        1. Process R&D
        2. Custom Synthesis
        3. Others
      4. Chemistry
        1. Medicinal Chemistry
        2. Computation Chemistry
      5. Safety Pharmacology
      6. Others
    3. Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
      1. Patient-Derived Organoid (PDO) Model
      2. Patient-Derived Xenograft Model
    4. Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Neurology
      3. Cardiology
      4. Infectious Diseases
      5. Metabolic Disorders
      6. Others
    5. Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnological Companies
      2. Government and Academic Institutes
      3. Medical Device Companies
      4. Others
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
  8. Europe Preclinical CRO Market Size Analysis
    1. Introduction
    2. Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Bioanalysis and DMPK studies
        1. In vitro ADME
        2. In-vivo PK
      2. Toxicology Testing
        1. GLP
        2. Non-GLP
      3. Compound Management
        1. Process R&D
        2. Custom Synthesis
        3. Others
      4. Chemistry
        1. Medicinal Chemistry
        2. Computation Chemistry
      5. Safety Pharmacology
      6. Others
    3. Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
      1. Patient-Derived Organoid (PDO) Model
      2. Patient-Derived Xenograft Model
    4. Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Neurology
      3. Cardiology
      4. Infectious Diseases
      5. Metabolic Disorders
      6. Others
    5. Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnological Companies
      2. Government and Academic Institutes
      3. Medical Device Companies
      4. Others
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    8. France
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
  9. APAC Preclinical CRO Market Size Analysis
    1. Introduction
    2. Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Bioanalysis and DMPK studies
        1. In vitro ADME
        2. In-vivo PK
      2. Toxicology Testing
        1. GLP
        2. Non-GLP
      3. Compound Management
        1. Process R&D
        2. Custom Synthesis
        3. Others
      4. Chemistry
        1. Medicinal Chemistry
        2. Computation Chemistry
      5. Safety Pharmacology
      6. Others
    3. Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
      1. Patient-Derived Organoid (PDO) Model
      2. Patient-Derived Xenograft Model
    4. Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Neurology
      3. Cardiology
      4. Infectious Diseases
      5. Metabolic Disorders
      6. Others
    5. Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnological Companies
      2. Government and Academic Institutes
      3. Medical Device Companies
      4. Others
    6. China
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    9. India
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    11. Singapore
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    12. Taiwan
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    13. South East Asia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    14. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
  10. Middle East and Africa Preclinical CRO Market Size Analysis
    1. Introduction
    2. Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Bioanalysis and DMPK studies
        1. In vitro ADME
        2. In-vivo PK
      2. Toxicology Testing
        1. GLP
        2. Non-GLP
      3. Compound Management
        1. Process R&D
        2. Custom Synthesis
        3. Others
      4. Chemistry
        1. Medicinal Chemistry
        2. Computation Chemistry
      5. Safety Pharmacology
      6. Others
    3. Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
      1. Patient-Derived Organoid (PDO) Model
      2. Patient-Derived Xenograft Model
    4. Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Neurology
      3. Cardiology
      4. Infectious Diseases
      5. Metabolic Disorders
      6. Others
    5. Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnological Companies
      2. Government and Academic Institutes
      3. Medical Device Companies
      4. Others
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
  11. LATAM Preclinical CRO Market Size Analysis
    1. Introduction
    2. Preclinical CRO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Bioanalysis and DMPK studies
        1. In vitro ADME
        2. In-vivo PK
      2. Toxicology Testing
        1. GLP
        2. Non-GLP
      3. Compound Management
        1. Process R&D
        2. Custom Synthesis
        3. Others
      4. Chemistry
        1. Medicinal Chemistry
        2. Computation Chemistry
      5. Safety Pharmacology
      6. Others
    3. Preclinical CRO Market Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
      1. Patient-Derived Organoid (PDO) Model
      2. Patient-Derived Xenograft Model
    4. Preclinical CRO Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Neurology
      3. Cardiology
      4. Infectious Diseases
      5. Metabolic Disorders
      6. Others
    5. Preclinical CRO Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnological Companies
      2. Government and Academic Institutes
      3. Medical Device Companies
      4. Others
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Bioanalysis and DMPK studies
          1. In vitro ADME
          2. In-vivo PK
        2. Toxicology Testing
          1. GLP
          2. Non-GLP
        3. Compound Management
          1. Process R&D
          2. Custom Synthesis
          3. Others
        4. Chemistry
          1. Medicinal Chemistry
          2. Computation Chemistry
        5. Safety Pharmacology
        6. Others
      3. Market Size & Forecast By Model 2022-2034 (USD MILLION/ Units)
        1. Patient-Derived Organoid (PDO) Model
        2. Patient-Derived Xenograft Model
      4. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnological Companies
        2. Government and Academic Institutes
        3. Medical Device Companies
        4. Others
  12. Competitive Landscape
    1. Preclinical CRO Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Charles River Laboratories International, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Covance Inc.
    3. ICON plc
    4. Medpace, Inc.
    5. WuXi AppTec
    6. Envigo
    7. PRA Health Sciences
    8. Syngene International Limited
    9. Eurofins Scientific
    10. Parexel International Corporation
    11. SGS SA
    12. MPI Research
    13. Crown Bioscience, Inc.
    14. Toxikon Corporation
    15. Pharmaron
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.